Article
NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.
International journal of hematology - 1 Nov 2017
Hara Ryujiro, Onizuka Makoto, Matsusita Erika, Kikkawa Eri, Nakamura Yoshihiko, Matsushita Hiromichi, Ohgiya Daisuke, Murayama Hiromichi, Machida Shinichiro, Ohmachi Ken, Shirasugi Yukari, Ogawa Yoshiaki, Kawada Hiroshi, Ando Kiyoshi
Abstract excerpt
A recent study reported that treatment-free remission (TFR) of chronic myeloid leukemia (CML) after dasatinib (Das) treatment was significantly associated with natural killer (NK) cell proliferation in the peripheral blood. However, biomarkers to predict lymphocytosis or successful TFR are not well characterized. In order to clarify individual differences in NK cell responses among patients treated with Das, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
